Praxis Precision Medicines Inc (PRAX)

Feb 21, 2025

Long Term Trading Analysis for (PRAX) - Stock Traders Daily

Feb 21, 2025

Feb 21, 2025

CIBC Asset Management Inc Purchases 117,817 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Feb 21, 2025

Feb 20, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Trading Up 4.9%Here's Why - MarketBeat

Feb 20, 2025

Feb 20, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Sees Significant Growth in Short Interest - MarketBeat

Feb 20, 2025

Feb 19, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 8.6%Should You Sell? - MarketBeat

Feb 19, 2025

Feb 18, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Hits New 1-Year HighWhat's Next? - MarketBeat

Feb 18, 2025

Feb 16, 2025

Jefferies maintains Praxis stock with $305 target, bullish on catalysts - MSN

Feb 16, 2025

Feb 15, 2025

Mirae Asset Global Investments Co. Ltd. Takes $48,000 Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World

Feb 15, 2025

Feb 15, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Shares Down 6.5%Here's What Happened - MarketBeat

Feb 15, 2025

Feb 15, 2025

Deutsche Bank Aktiengesellschaft Begins Coverage on Praxis Precision Medicines (NASDAQ:PRAX) - MarketBeat

Feb 15, 2025

Feb 14, 2025

PRAX stock soars to 52-week high, hits $90.33 amid robust gains - MSN

Feb 14, 2025

Feb 14, 2025

PRAX stock soars to 52-week high, hits $90.33 amid robust gains By Investing.com - Investing.com South Africa

Feb 14, 2025

Feb 13, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Earns "Buy" Rating from Needham & Company LLC - MarketBeat

Feb 13, 2025

Feb 11, 2025

Deutsche Bank sets $111 target for Praxis Precision shares By Investing.com - Investing.com Nigeria

Feb 11, 2025

Feb 11, 2025

Deutsche Bank Initiates Coverage of Praxis Precision Medicines (PRAX) with Buy Recommendation - Nasdaq

Feb 11, 2025

Feb 11, 2025

The Analyst Verdict: Praxis Precision Medicine In The Eyes Of 4 Experts - Benzinga

Feb 11, 2025

Feb 11, 2025

What the Options Market Tells Us About Praxis Precision Medicine - Benzinga

Feb 11, 2025

Feb 11, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 6.5% – Time to Sell? - Defense World

Feb 11, 2025

Feb 11, 2025

Deutsche Bank sets $111 target for Praxis Precision shares - MSN

Feb 11, 2025

Feb 11, 2025

Deutsche Bank Initiates Coverage on Praxis Precision Medicines With Buy Rating, $111 Price Target - Marketscreener.com

Feb 11, 2025

Feb 11, 2025

Praxis Precision Medicines’ (PRAX) “Buy” Rating Reaffirmed at Needham & Company LLC - Defense World

Feb 11, 2025

Feb 09, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 1-Year HighHere's Why - MarketBeat

Feb 09, 2025

Feb 08, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Up 5.8%What's Next? - MarketBeat

Feb 08, 2025

Feb 07, 2025

China Universal Asset Management Co. Ltd. Makes New Investment in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Feb 07, 2025

Feb 05, 2025

Morgan Stanley's Strategic Acquisition of Praxis Precision Medic - GuruFocus.com

Feb 05, 2025

Feb 05, 2025

Should You Invest in Nasdaq Inc (NDAQ) Now? - The News Heater

Feb 05, 2025

Feb 04, 2025

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Feb 04, 2025

Feb 04, 2025

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Inc.

Feb 04, 2025

Feb 04, 2025

Praxis Awards Strategic Compensation Package: $80.26 Options Grant Signals Talent Acquisition Push - StockTitan

Feb 04, 2025

Feb 03, 2025

Praxis Precision Medicines to Present at Two February Investor Conferences - The Manila Times

Feb 03, 2025

Feb 03, 2025

CNS Drug Developer Praxis Lines Up Exclusive Investor Access at Guggenheim & Oppenheimer Events - StockTitan

Feb 03, 2025

Feb 01, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives $149.11 Average Price Target from Brokerages - MarketBeat

Feb 01, 2025

Jan 30, 2025

Learn to Evaluate (PRAX) using the Charts - Stock Traders Daily

Jan 30, 2025

Jan 29, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Purchased by JPMorgan Chase & Co. - Defense World

Jan 29, 2025

Jan 29, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jan 29, 2025

Jan 23, 2025

Praxis Precision Medicines (PRAX) Stock Price, News & Analysis - MarketBeat

Jan 23, 2025

Jan 22, 2025

Noteworthy Wednesday Option Activity: PRAX, ORCL, SOC - Nasdaq

Jan 22, 2025

Jan 22, 2025

Jefferies maintains Praxis stock with $305 target, bullish on catalysts By Investing.com - Investing.com South Africa

Jan 22, 2025

Jan 22, 2025

Truist Financial Issues Positive Forecast for Praxis Precision Medicines (NASDAQ:PRAX) Stock Price - Defense World

Jan 22, 2025

Jan 22, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Shares Up 8.5% Following Analyst Upgrade - Defense World

Jan 22, 2025

Jan 21, 2025

Expert Outlook: Praxis Precision Medicine Through The Eyes Of 5 Analysts - Benzinga

Jan 21, 2025